文献速递免疫规划卫生政策与健康促进

2019年法国男男性行为者人乳头瘤病毒疾病疫苗接种覆盖率低

Low vaccination coverage for human papillomavirus disease among young men who have sex with men, France, 2019.
PubMed 文献 · Euro Surveill · 2021-01-01

2019年法国在线横断面调查纳入9469名18-28岁男男性行为者,15%(95%CI:14-16)报告至少接种一剂HPV疫苗。接种率在<24岁、学历低于大学、农村居住、参加性派对、使用HIV生物医学预防方法、有性传播感染诊断及接种甲肝或乙肝疫苗者中较高。作者认为接种率不理想,需进一步努力改善该人群HPV疫苗接种覆盖。

要点

  • 2019年法国18-28岁MSM中15%(95%CI:14-16)报告接种至少一剂HPV疫苗。
  • 接种率在<24岁、农村居住、使用HIV生物医学预防方法及接种甲肝或乙肝疫苗者中较高。
  • 作者认为MSM HPV疫苗接种率不理想,需进一步努力改善覆盖。

核心结论

  • 法国MSM的HPV疫苗接种率不令人满意。
  • 接种率在受益于其他疫苗和针对HIV的生物医学预防方法的MSM中较高,提示国家预防性健康建议对MSM有协同效应。
  • 作者认为需要进一步努力改善针对MSM的HPV疫苗接种覆盖。

研究设计与样本

  • 2019年开展的自愿性横断面在线调查,针对MSM。
  • 共9469名受访者,年龄范围18-28岁。
  • 使用泊松回归计算至少一剂HPV疫苗覆盖率和决定因素的患病率比(PR)及95%置信区间(CI)。

主要发现

  • 15%(95%CI:14-16)的受访者报告接种过HPV疫苗。
  • 接种覆盖率在<24岁MSM中显著更高(PR:1.25;95%CI:1.13-1.39)。
  • 接种覆盖率在学历低于大学学位者中显著更高(PR:1.12;95%CI:1.08-1.32)。
  • 接种覆盖率在农村地区居住者中显著更高(PR:1.21;95%CI:1.08-1.36)。
  • 接种覆盖率在参加性派对者中显著更高(PR:1.12;95%CI:1.03-1.33);使用HIV相关生物医学预防方法者PR:1.31(95%CI:1.12-1.54);有STI诊断者PR:1.22(95%CI:1.08-1.38);接种甲肝或乙肝疫苗者PR:4.56(95%CI:3.63-5.81)vs PR:3.35(95%CI:2.53-4.44)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundIn France, human papillomavirus (HPV) vaccination has been recommended in 2016 for men who have sex with men (MSM) up to age 26 years.AimWe aimed to estimate HPV vaccine coverage in 18-28 year-old MSM and identify uptake determinants.MethodsWe collected data on socio-demographic characteristics, sexual behaviour, sexually transmitted diseases (STI) screening and vaccination uptake using a voluntary cross-sectional online survey conducted in 2019 targeting MSM. We calculated coverage of at least one dose of HPV vaccine and prevalence ratios (PR) of determinants with 95% confidence intervals (CI) using Poisson regression.ResultsOf 9,469 respondents (age range: 18-28 years), 15% (95% CI: 14-16) reported being vaccinated for HPV. Coverage was significantly higher among MSM < 24 years (PR: 1.25; 95% CI: 1.13-1.39), with education level below university degree (PR: 1.12; 95% CI: 1.08-1.32), living in rural areas (PR: 1.21; 95% CI: 1.08-1.36), attending sex parties (PR: 1.12; 95% CI: 1.03-1.33), using HIV-related biomedical prevention methods (PR: 1.31; 95% CI: 1.12-1.54), with STI diagnosis (PR: 1.22; 95% CI: 1.08-1.38) and with hepatitis A or B vaccination (PR: 4.56; 95% CI: 3.63-5.81 vs PR: 3.35; 95% CI: 2.53-4.44).ConclusionsThe HPV vaccination uptake among MSM in France was not satisfactory. It was higher among MSM benefitting from other vaccinations and biomedical preventive methods against HIV, suggesting a synergistic effect of the national preventive sexual health recommendations for MSM. Further efforts to improve HPV vaccination coverage targeting MSM are warranted.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Ortu G, Barret AS, Danis K, et al. Low vaccination coverage for human papillomavirus disease among young men who have sex with men, France, 2019. Euro Surveill. 2021. PMID: 34915971. doi:10.2807/1560-7917.ES.2021.26.50.2001965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。